KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Convertible Debt (2020 - 2025)

Neogenomics (NEO) has disclosed Convertible Debt for 6 consecutive years, with $341.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Convertible Debt changed 0.45% year-over-year to $341.9 million, compared with a TTM value of $341.9 million through Dec 2025, changed 0.45%, and an annual FY2025 reading of $341.9 million, changed 0.45% over the prior year.
  • Convertible Debt was $341.9 million for Q4 2025 at Neogenomics, roughly flat from $341.5 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $538.9 million in Q1 2024 and bottomed at $339.6 million in Q2 2024.
  • Average Convertible Debt over 5 years is $466.8 million, with a median of $532.1 million recorded in 2021.
  • The sharpest move saw Convertible Debt skyrocketed 222.76% in 2021, then tumbled 36.78% in 2025.
  • Year by year, Convertible Debt stood at $532.5 million in 2021, then grew by 0.53% to $535.3 million in 2022, then rose by 0.54% to $538.2 million in 2023, then crashed by 36.76% to $340.3 million in 2024, then rose by 0.45% to $341.9 million in 2025.
  • Business Quant data shows Convertible Debt for NEO at $341.9 million in Q4 2025, $341.5 million in Q3 2025, and $341.1 million in Q2 2025.